38 related articles for article (PubMed ID: 19829031)
1. The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer: Gunma Urological Oncology Study Group investigation.
Imai K; Suzuki T; Kobayashi M; Yamanaka H; Tomaru Y; Sato J
Jpn J Cancer Res; 1990 Oct; 81(10):971-4. PubMed ID: 2121683
[TBL] [Abstract][Full Text] [Related]
2. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
3. Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
Baum YS; Patil D; Huang JH; Spetka S; Torlak M; Nieh PT; Alemozaffar M; Ogan K; Master VA
Asian J Urol; 2016 Jan; 3(1):20-25. PubMed ID: 29264158
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.
Cescon M; Bertuzzo VR; Ercolani G; Ravaioli M; Odaldi F; Pinna AD
World J Gastroenterol; 2013 Dec; 19(48):9174-82. PubMed ID: 24409045
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
Int J Surg Oncol; 2012; 2012():524981. PubMed ID: 22900160
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of systemic inflammatory response in renal cell carcinoma: a systematic review and meta-analysis.
Wu Y; Fu X; Zhu X; He X; Zou C; Han Y; Xu M; Huang C; Lu X; Zhao Y
J Cancer Res Clin Oncol; 2011 May; 137(5):887-96. PubMed ID: 20878529
[TBL] [Abstract][Full Text] [Related]
7. [Sedimentation rate and renal cancer].
Iversen OH; Røger M; Wetteland P; Solberg HE
Tidsskr Nor Laegeforen; 1997 Jun; 117(17):2493-6. PubMed ID: 9265313
[TBL] [Abstract][Full Text] [Related]
8. Complexity of tumor vasculature in clear cell renal cell carcinoma.
Qian CN; Huang D; Wondergem B; Teh BT
Cancer; 2009 May; 115(10 Suppl):2282-9. PubMed ID: 19402071
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
Lee SE; Byun SS; Han JH; Han BK; Hong SK
BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
[TBL] [Abstract][Full Text] [Related]
10. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
11. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma.
Hannisdal E; Bostad L; Grøttum KA; Langmark F
Eur J Surg Oncol; 1989 Aug; 15(4):333-6. PubMed ID: 2759251
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
14. Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.
Kawai Y; Matsuyama H; Korenaga Y; Misumi T; Eguchi S; Hara T; Nagao K; Ohmi C; Sakano S; Naito K
Urol Int; 2009; 83(3):306-10. PubMed ID: 19829031
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
